-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Nabriva Therapeutics plc quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2015 to Q2 2023.
- Nabriva Therapeutics plc Earnings Per Share, Basic for the quarter ending June 30, 2023 was -3.73 USD/shares, a 14.8% increase year-over-year.
- Nabriva Therapeutics plc Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -18.4 USD/shares, a 50.5% increase year-over-year.
- Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2022 was -21.3 USD/shares, a 25.2% increase from 2021.
- Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2021 was -28.5 USD/shares, a 78.9% increase from 2020.
- Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2020 was -135 USD/shares, a 1113% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)